Source: European Journal of Medicinal Chemistry. Unidades: FFCLRP, FCFRP
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHIERRITO, Talita P. C. et al. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease. European Journal of Medicinal Chemistry, v. 139, p. 773-791, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2017.08.051. Acesso em: 01 maio 2024.APA
Chierrito, T. P. C., Mantoani, S. P., Roca, C., Requena, C., Perez, V. S., Castillo, W. O., et al. (2017). From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease. European Journal of Medicinal Chemistry, 139, 773-791. doi:10.1016/j.ejmech.2017.08.051NLM
Chierrito TPC, Mantoani SP, Roca C, Requena C, Perez VS, Castillo WO, Moreira NCS, Pérez C, Sakamoto-Hojo ET, Takahashi CS, Barbero JJ, Cañada FJ, Campillo NE, Martinez A, Carvalho I. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease [Internet]. European Journal of Medicinal Chemistry. 2017 ; 139 773-791.[citado 2024 maio 01 ] Available from: https://doi.org/10.1016/j.ejmech.2017.08.051Vancouver
Chierrito TPC, Mantoani SP, Roca C, Requena C, Perez VS, Castillo WO, Moreira NCS, Pérez C, Sakamoto-Hojo ET, Takahashi CS, Barbero JJ, Cañada FJ, Campillo NE, Martinez A, Carvalho I. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: a new avenue for disease-modifying drugs in Alzheimer's disease [Internet]. European Journal of Medicinal Chemistry. 2017 ; 139 773-791.[citado 2024 maio 01 ] Available from: https://doi.org/10.1016/j.ejmech.2017.08.051